Sunam Mander Selected Research

SP-8356

5/2021	SP-8356, a (1S)-(-)-Verbenone Derivative, Inhibits the Growth and Motility of Liver Cancer Cells by Regulating NF-κB and ERK Signaling.
1/2019	SP-8356, a (1S)-(-)-verbenone derivative, exerts in vitro and in vivo anti-breast cancer effects by inhibiting NF-κB signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sunam Mander Research Topics

Disease

5	Neoplasms (Cancer) 01/2023 - 02/2018
3	Breast Neoplasms (Breast Cancer) 02/2022 - 02/2018
2	Brain Neoplasms (Brain Tumor) 01/2023 - 01/2022
2	Neoplasm Metastasis (Metastasis) 05/2021 - 02/2018
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Liver Neoplasms (Liver Cancer) 05/2021
1	Triple Negative Breast Neoplasms 02/2018
1	Lung Neoplasms (Lung Cancer) 12/2016

Drug/Important Bio-Agent (IBA)

2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2022
2	SP-8356IBA 05/2021 - 01/2019
2	verbenoneIBA 05/2021 - 01/2019
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Temozolomide (Temodar)FDA LinkGeneric 01/2022
1	Cell-Penetrating PeptidesIBA 01/2022
1	Coloring Agents (Dyes)IBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 05/2021
1	NF-kappa B (NF-kB)IBA 05/2021
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 02/2018
1	ErbB Receptors (EGF Receptor)IBA 02/2018
1	nafamostatIBA 02/2018
1	Progesterone Receptors (Progesterone Receptor)IBA 02/2018
1	Metalloproteases (Metalloproteinases)IBA 02/2018
1	Transcription Factors (Transcription Factor)IBA 02/2018
1	Proteins (Proteins, Gene)FDA Link 12/2016

Therapy/Procedure

2	Computer-Assisted Surgery (Image Guided Surgery) 02/2022 - 01/2022
2	Therapeutics 01/2022 - 02/2018
1	Adjuvant Chemotherapy 01/2022
1	Drug Therapy (Chemotherapy) 05/2021